Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
COLLEGIUM PHARMACEUTICAL, INC (COLL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
8-K
| Investor presentation, Quarterly results |
| 05/04/2023 |
8-K
| Investor presentation, Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 08/04/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
8-K
| Quarterly results |
| 02/24/2022 |
8-K
| Quarterly results |
| 11/04/2021 |
8-K
| Quarterly results |
| 08/05/2021 |
8-K
| Quarterly results |
| 05/06/2021 |
8-K
| Quarterly results |
| 02/25/2021 |
8-K
| Quarterly results |
| 11/05/2020 |
8-K
| Quarterly results |
| 08/05/2020 |
8-K
| Quarterly results |
| 05/07/2020 |
8-K
| Quarterly results |
| 02/27/2020 |
8-K
| Quarterly results |
| 11/06/2019 |
8-K
| Quarterly results |
| 08/07/2019 |
8-K
| Quarterly results |
| 05/08/2019 |
8-K
| Quarterly results |
| 02/27/2019 |
8-K
| Quarterly results |
| 11/08/2018 |
8-K
| Quarterly results|
Docs:
|
"Warrant, issued November 8, 2018",
"Amendment No. 3 to Commercialization Agreement, by and among Collegium Pharmaceutical, Inc., Collegium NF, LLC, and Assertio Therapeutics, Inc",
"Collegium Reports Third Quarter Financial Results" |
|
| 08/08/2018 |
8-K
| Quarterly results |
| 05/09/2018 |
8-K
| Quarterly results |
| 03/07/2018 |
8-K
| Quarterly results |
| 11/08/2017 |
8-K
| Quarterly results |
| 08/09/2017 |
8-K
| Quarterly results |
| 05/10/2017 |
8-K
| Form 8-K - Current report |
| 03/09/2017 |
8-K
| Form 8-K - Current report |
| 11/10/2016 |
8-K
| Form 8-K - Current report |
| 08/10/2016 |
8-K
| Quarterly results |
|
|